CG
Caforio Giovanni
Chairman & CEO
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Caforio Giovanni, Chairman & CEO. Officer active across 2 companies, notably Bristol Myers Squibb Co. Cumulatively, 19 filings have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €32.4m. Activity tracked since 2 August 2021. The latest transaction was disclosed on 8 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations19 total
560 shares0Common StockSEC:0000310764-25-000078:0
653 shares0Common StockSEC:0000310764-24-000071:0
23,409 shares0Common Stock, $0.10 par valueSEC:0000014272-24-000052:0
440 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000177:0
705 shares0Common StockSEC:0000310764-23-000079:0
841 shares0Common StockSEC:0000310764-23-000073:0
24,793 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000055:0
240,000 shares@ US$74.6551.3% of flowCommon Stock, $0.10 par valueSEC:0000014272-23-000044:0
25,000 shares@ US$69.715.4% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000174:0
50,000 shares@ US$71.8411.1% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000172:0
30,000 shares@ US$74.0420.5% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000126:0
693 shares0Common StockSEC:0000310764-22-000077:0
25,000 shares@ US$71.5215.5% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000092:0
18,726 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000079:0
30,000 shares@ US$67.0017.1% of flowCommon Stock, $0.10 par valueSEC:0000014272-22-000053:0
25,000 shares@ US$60.6412.4% of flowCommon Stock, $0.10 par valueSEC:0000014272-21-000204:0
25,000 shares@ US$60.644.0% of flowCommon Stock, $0.10 par valueSEC:0000014272-21-000204
20,000 shares@ US$68.5811.1% of flowCommon Stock, $0.10 par valueSEC:0000014272-21-000200:0
20,000 shares@ US$68.583.6% of flowCommon Stock, $0.10 par valueSEC:0000014272-21-000200
About Caforio Giovanni
Giovanni Caforio is the Chairman and CEO of Bristol Myers Squibb Co. and Stryker Corp. He leads these companies with a strategic vision focused on innovation in the pharmaceutical and medical sectors. His leadership is crucial for growth and the development of new treatments.